|
1
|
Siegel RL, Naishadham D and Jemal A:
Cancer statistics, 2013. CA Cancer J Clin. 63:11–30. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brenton JD, Carey LA, Ahmed AA and Caldas
C: Molecular classification and molecular forecasting of breast
cancer: Ready for clinical application? J Clin Oncol. 23:7350–7360.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cleator S, Heller W and Coombes RC:
Triple-negative breast cancer: Therapeutic options. Lancet Oncol.
8:235–244. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Foulkes WD, Smith IE and Reisfilho JS:
Triple-negative breast cancer. N Engl J Med. 363:1938–1948. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calle EE and Kaaks R: Overweight, obesity
and cancer: Epidemiological evidence and proposed mechanisms. Nat
Rev Cancer. 4:579–591. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nieman K, Romero IL, Van Houten B and
Lengyel E: Adipose tissue and adipocytes support tumorigenesis and
metastasis. Biochim Biophys Acta. 1831:1533–1541. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bifulco M and Pisanti S: ‘Adiponcosis’: A
new term to name the obesity and cancer link. J Clin Endocrinol
Metab. 98:4664–4665. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Iyengar P, Combs TP, Shah SJ, Gouon-Evans
V, Pollard JW, Albanese C, Flanagan L, Tenniswood MP, Guha C,
Lisanti MP, et al: Adipocyte-secreted factors synergistically
promote mammary tumorigenesis through induction of anti-apoptotic
transcriptional programs and proto-oncogene stabilization.
Oncogene. 22:6408–6423. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Park J, Morley TS, Kim M, Clegg DJ and
Scherer PE: Obesity and cancer-mechanisms underlying tumour
progression and recurrence. Nat Rev Endocrinol. 10:455–465. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
D’Esposito V, Passaretti F, Hammarstedt A,
Liguoro D, Terracciano D, Molea G, Canta L, Miele C, Smith U,
Beguinot F and Formisano P: Adipocyte-released insulin-like growth
factor-1 is regulated by glucose and fatty acids and controls
breast cancer cell growth in vitro. Diabetologia. 55:2811–2822.
2012. View Article : Google Scholar :
|
|
13
|
Luboshits G, Shina S, Kaplan O, Engelberg
S, Nass D, Lifshitz-Mercer B, Chaitchik S, Keydar I and Ben-Baruch
A: Elevated expression of the CC chemokine regulated on activation,
normal T cell expressed and secreted (RANTES) in advanced breast
carcinoma. Cancer Res. 59:4681–4687. 1999.PubMed/NCBI
|
|
14
|
Balkwill FR: Cancer and the chemokine
network. Nat Rev Cancer. 4:540–550. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Azenshtein E, Luboshits G, Shina S,
Neumark E, Shahbazian D, Weil M, Wigler N, Keydar I and Ben-Baruch
A: The CC chemokine RANTES in breast carcinoma progression:
Regulation of expression and potential mechanisms of promalignant
activity. Cancer Res. 62:1093–1102. 2002.PubMed/NCBI
|
|
16
|
D’Esposito V, Liguoro D, Ambrosio MR,
Collina F, Cantile M, Spinelli R, Raciti GA, Miele C, Valentino R,
Campiglia P, et al: Adipose microenvironment promotes triple
negative breast cancer cell invasiveness and dissemination by
producing CCL5. Oncotarget. 7:24495–24509. 2016.
|
|
17
|
Lee Y, Jung WH and Koo JS: Adipocytes can
induce epithelial-mesenchymal transition in breast cancer cells.
Breast Cancer Res Treat. 153:323–335. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang L, Lin C and Liu ZR: P68 RNA helicase
mediates PDGF-induced epithelial mesenchymal transition by
displacing Axin from beta-catenin. Cell. 127:139–155. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shang X and Yuan Z: Determination of six
components in Rhubarb by cyclodextrin-modified micellar
electrokinetic chromatography using a mixed micellar system of
sodium cholate and sodium taurocholate. Analytica Chimica Acta.
456:183–188. 2002. View Article : Google Scholar
|
|
20
|
Xia XM, Li BK, Xing SM and Ruan HL: Emodin
promoted pancreatic claudin-5 and occludin expression in
experimental acute pancreatitis rats. World J Gastroenterol.
18:2132–2139. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou M, Xu H, Pan L, Wen J, Guo Y and Chen
K: Emodin promotes atherosclerotic plaque stability in fat-fed
apolipoprotein E-deficient mice. Tohoku J Exp Med. 215:61–69. 2008.
View Article : Google Scholar
|
|
22
|
Guo J, Li W, Shi H, Xie X, Li LR, Tang H,
Wu M, Kong Y, Yang L, Gao J, et al: Synergistic effects of curcumin
with emodin against the proliferation and invasion of breast cancer
cells through upregulation of miR-34a. Mol Cell Biochem.
382:103–111. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang Z, Chen G and Shi P: Effects of
emodin on the gene expression profiling of human breast carcinoma
cells. Cancer Detect Prev. 32:286–291. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zu C, Zhang M, Xue H, Cai X, Zhao L, He A,
Qin G, Yang C and Zheng X: Emodin induces apoptosis of human breast
cancer cells by modulating the expression of apoptosis-related
genes. Oncol Lett. 10:2919–2924. 2015. View Article : Google Scholar
|
|
25
|
Lin SZ, Wei WT, Chen H, Chen KJ, Tong HF,
Wang ZH, Ni ZL, Liu HB, Guo HC and Liu DL: Antitumor activity of
emodin against pancreatic cancer depends on its dual role:
Promotion of apoptosis and suppression of angiogenesis. PLoS One.
7:e421462012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu A, Sha L, Shen Y, Huang L, Tang X and
Lin S: Experimental study on anti-metastasis effect of emodin on
human pancreatic cancer. Zhongguo Zhong Yao Za Zhi. 36:3167–71.
2011.In Chinese.
|
|
27
|
He L, Bi JJ, Guo Q, Yu Y and Ye XF:
Effects of emodin extracted from Chinese herbs on proliferation of
non-small cell lung cancer and underlying mechanisms. Asian Pac J
Cancer Prev. 13:1505–1510. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yu JQ, Bao W and Lei JC: Emodin regulates
apoptotic pathway in human liver cancer cells. Phytother Res.
27:251–257. 2013. View
Article : Google Scholar
|
|
29
|
Cha TL, Qiu L, Chen CT, Wen Y and Hung MC:
Emodin down-regulates androgen receptor and inhibits prostate
cancer cell growth. Cancer Res. 65:2287–2295. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xue H, Chen Y, Cai X, Zhao L, He A, Guo K
and Zheng X: The combined effect of survivin-targeted shRNA and
emodin on the proliferation and invasion of ovarian cancer cells.
Anticancer Drugs. 24:937–944. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ma YS, Weng SW, Lin MW, Lu CC, Chiang JH,
Yang JS, Lai KC, Lin JP, Tang NY, Lin JG and Chung JG: Antitumor
effects of emodin on LS1034 human colon cancer cells in vitro and
in vivo: Roles of apoptotic cell death and LS1034 tumor xenografts
model. Food Chem Toxicol. 50:1271–1278. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang W, Sun Y, Li X, Li H, Chen Y, Tian Y,
Yi J and Wang J: Emodin potentiates the anticancer effect of
cisplatin on gallbladder cancer cells through the generation of
reactive oxygen species and the inhibition of survivin expression.
Oncol Rep. 26:1143–1148. 2011.PubMed/NCBI
|
|
33
|
Sun Y, Wang X, Zhou Q, Lu Y, Zhang H, Chen
Q, Zhao M and Su S: Inhibitory effect of emodin on migration,
invasion and metastasis of human breast cancer MDA-MB-231 cells in
vitro and in vivo. Oncol Rep. 33:338–346. 2015. View Article : Google Scholar
|
|
34
|
Yan Y, Su X, Liang Y, Zhang J, Shi C, Lu
Y, Gu L and Fu L: Emodin azide methyl anthraquinone derivative
triggers mitochondrial-dependent cell apoptosis involving in
caspase-8-mediated Bid cleavage. Mol Cancer Ther. 7:1688–1697.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Isakson P, Hammarstedt A, Gustafson B and
Smith U: Impaired preadipocyte differentiation in human abdominal
obesity: Role of Wnt, tumor necrosis factor-alpha, and
inflammation. Diabetes. 58:1550–1557. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Poulos SP, Hausman DB and Hausman GJ: The
development and endocrine functions of adipose tissue. Mol Cell
Endocrinol. 323:20–34. 2010. View Article : Google Scholar
|
|
37
|
Duband JL, Monier F, Delannet M and
Newgreen D: Epithelium-mesenchyme transition during neural crest
development. Acta Anat. 154:63–78. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kalluri R and Neilson EG:
Epithelial-mesenchymal transition and its implications for
fibrosis. J Clin Invest. 112:1776–1784. 2003. View Article : Google Scholar : PubMed/NCBI
|
